Latest News

The market has climbed 1.6% in the last 7 days, contributing to a remarkable 28% increase over the past year, with earnings expected to grow by 17% per annum in the coming years. Though 'penny stock' might sound like a relic of past trading days, it still points to opportunities in smaller or newer companies that can offer significant returns when built on solid financials. We've identified three penny stocks that combine balance sheet strength with potential for outsized gains, offering...

The United States market has shown resilience with a 1.6% increase in the past week and an impressive 28% rise over the last year, supported by forecasts of annual earnings growth at 17%. In this dynamic environment, identifying promising small-cap stocks that align with these positive trends can offer unique opportunities for investors seeking to uncover potential growth stories.

The United States market has shown robust performance recently, climbing 1.6% in the last week and 28% over the past year, with earnings anticipated to grow by 17% annually. In this thriving environment, selecting dividend stocks that offer reliable income and potential for capital appreciation can be a prudent strategy for investors seeking stability and growth.

If you are wondering whether FedEx at around US$411.75 is still offering value after a strong run, the key is to look closely at what the current price implies about the company. The stock has posted returns of 4.5% over the past week, 4.6% over the past month, 40.5% year to date and 93.2% over the past year, which naturally raises questions about growth potential and how much risk is already priced in. Recent coverage has focused on FedEx as a major global logistics player, with attention...

In May 2026, AGC Inc. completed third-party verification under UL 2809 confirming that, via a mass balance approach, 100% of the fluorine content in its high-performance AFLAS FFKM elastomer is attributed to recycled fluorite. This verification strengthens AGC’s push toward a circular economy for fluorine resources while offering semiconductor customers a combination of durability and lower environmental impact. We’ll now examine how AFLAS FFKM’s fully mass-balance-certified recycled...

The Goodyear Tire & Rubber Company recently issued US$750 million of senior, unsecured corporate notes due July 15, 2032, featuring attached guarantees and call provisions. This sizeable fixed-income offering sheds light on how Goodyear is managing its capital structure and future financing flexibility alongside its broader operations. Next, we’ll examine how this US$750 million senior unsecured bond issue could influence Goodyear’s investment narrative and balance sheet outlook. Find 46...

What triggered fresh interest in Dycom Industries stock? Dycom Industries (DY) drew fresh attention after reporting a strong first quarter, raising full-year and second-quarter revenue guidance, and announcing an agreement to acquire National Technology Integrators in the data center space. See our latest analysis for Dycom Industries. The stock has cooled slightly after the earnings spike, with the latest 1 day share price return down 4.7%. However, a 7 day share price return of 24.0% and a...

Conference spotlight and recent share performance Onto Innovation (ONTO) is set to present at TD Cowen's 54th Annual Technology, Media & Telecom Conference on May 27, 2026, an event that has drawn fresh attention to the stock. With the share price at US$258.24 at the last close and mixed short term returns, recent interest centers on how conference commentary might shape views on the business, valuation and overall company profile. See our latest analysis for Onto Innovation. Onto...

Earnings and dividend event in focus Mega Or Holdings (TASE:MGOR) has drawn investor attention after reporting first quarter 2026 earnings, with sales of ₪97.78 million and net income of ₪689.45 million, alongside a declared cash dividend of ₪1.04872 per share. See our latest analysis for Mega Or Holdings. The earnings release and upcoming cash dividend appear to be feeding into already strong momentum, with a 10.45% 1 month share price return and a very large 1 year total shareholder return...

In May 2026, Ryan Specialty Holdings increased its equity repurchase authorization by US$300 million to a total of US$600 million and prepared to showcase its specialty insurance platform at the William Blair Growth Stock Conference. Institutional investor Guardian Point Capital’s additional 75,000-share purchase, alongside strong first-quarter revenue and earnings growth, underscored growing confidence in Ryan Specialty’s technology- and data-focused model. With expanded buyback capacity...

Equinor (OB:EQNR) is set to appoint Jarle Roth as its new chairman. The change follows the resignation of current chairman Jon Erik Reinhardsen after nearly a decade in the role. The proposed transition marks a significant governance shift for Equinor at a key point for the company and its stakeholders. Equinor operates as a major energy company, with activities that span traditional oil and gas as well as low carbon solutions. Board level changes at a business of this scale can influence...

Wyndham Hotels & Resorts recently launched a native ChatGPT app, enabling travelers to explore its roughly 8,400‑hotel portfolio with conversational AI, while also announcing that Chief Accounting Officer Nicola Rossi will leave on July 31, 2026, to be succeeded by longtime finance executive Christopher Androski. This combination of AI-driven booking capabilities and an internally sourced leadership transition in a core finance role highlights Wyndham’s emphasis on both digital innovation...

Why Oscar Health is on investors’ radar today Oscar Health (OSCR) is attracting fresh attention after recent trading, with the stock last closing at US$22.23. Investors are weighing this price against the company’s recent returns and fundamentals. See our latest analysis for Oscar Health. Recent trading has been choppy, with the share price down 0.45% over the last day and 1.81% over the week. Even so, the 30 day share price return of 20.23% and year to date share price return of 48.5% sit...

Biogen Inc. and Denali Therapeutics Inc. recently reported that their Phase 2b LUMA study of BIIB122 in early-stage Parkinson’s disease failed to meet its primary and secondary efficacy endpoints, leading them to discontinue development of the drug for idiopathic Parkinson’s disease while continuing a separate Phase 2a study in LRRK2 variant carriers. Despite missing clinical endpoints, the trial confirmed strong target engagement with high peripheral LRRK2 kinase inhibition and CSF...

Sinch (OM:SINCH) has drawn investor attention after recent share price moves, with the stock showing double digit returns over the past month and the past 3 months, prompting a closer look at its current valuation. See our latest analysis for Sinch. At a share price of SEK39.58, Sinch has seen strong share price momentum, with a 37.48% 1 month share price return and a 79.34% 3 month share price return, alongside a 56.32% 1 year total shareholder return that contrasts with a much weaker 5 year...

Pilgrim's Pride recently reported fiscal first-quarter 2026 results showing sales growth across several segments but weaker overall profitability and an earnings miss. Within these mixed results, the Just Bare brand stood out with very strong year-over-year sales growth, supported by ongoing investment in new facilities. Now we’ll examine how the profit pressure alongside Just Bare’s rapid expansion could influence Pilgrim’s Pride’s broader investment narrative. The best AI stocks today may...

Cognizant Technology Solutions recently expanded its AI footprint by partnering with Travelport to embed Anthropic’s Claude into travel retail platforms and by launching agent-powered Electronic Prior Authorization APIs on its TriZetto Unify healthcare platform, extending AI deeper into both travel and U.S. healthcare workflows. By exposing TriZetto services as headless, agent-ready APIs aligned with HL7 FHIR standards and supporting the Model Context Protocol, Cognizant is positioning its...

In recent days, Moderna announced an expanded collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI), which will provide up to US$50 million to support preclinical and Phase 1 development of its investigational Bundibugyo ebolavirus (BDBV) vaccine candidate. This partnership highlights how Moderna is using its mRNA platform beyond respiratory viruses, extending into emerging infectious diseases such as Ebola during an active outbreak in the Democratic Republic of...

Aura Minerals (AUGO) put its growth plans in front of investors during a Renmark virtual non deal roadshow on May 25, outlining recent production gains, new assets and progress on development projects. See our latest analysis for Aura Minerals. The Renmark roadshow comes after a mixed stretch for the stock, with a 1-day share price return of 1.83% and 7-day share price return of 6.46%. However, the 30-day share price return fell 5.95%, while a year-to-date share price return of 54.54% and a...

AeroVironment recently faced investor lawsuits and a terminated BADGER antenna contract for the Space Force’s SCAR program, while also securing several new U.S. government awards, including a US$20.2 million investment to expand its Huntsville missile facility and a US$20 million Air Force Research Laboratory CAMP materials contract. This mix of legal and program risk alongside fresh funding for counter‑UAS production, advanced materials, and AV_Halo software underscores how dependent...

Why Zai Lab (ZLAB) is on investors’ radar Zai Lab (ZLAB) has been drawing attention after recent share price pressure, with the stock down 4.3% over the past day and 17.9% over the past month, prompting investors to reassess its fundamentals. At a recent close of US$17.69 and a market value of about US$2.0b, the biopharmaceutical company reports annual revenue of US$453.28 million and a net loss of US$178.12 million, reflecting an early stage earnings profile. See our latest analysis for Zai...

Elanco Animal Health has begun a phased U.S. launch of Befrena (tirnovetmab), an anti‑IL‑31 monoclonal antibody injection for canine allergic and atopic dermatitis, offering 6 to 8 weeks of itch relief and rapid onset in Early Experience Program clinics. The product expands Elanco’s dermatology and monoclonal antibody lineup, making it the only pet health company with two USDA‑approved mAb therapies and broadening its presence in pet allergy care. We’ll now examine how Befrena’s...

Isracard (TASE:ISCD) released first quarter 2026 results that show ILS 850 million in revenue, ILS 45 million in net income and basic earnings per share of ILS 0.14 from continuing operations, attracting fresh attention to the stock. See our latest analysis for Isracard. The latest earnings release comes after a weaker run in the share price, with Isracard’s 30 day share price return down 15.59% and the year to date share price return down 19.05%. At the same time, the 1 year total...

Sano Bruno's Enterprises (TASE:SANO1) has drawn investor attention after reporting first quarter 2026 earnings, with sales of ₪590.67 million and net income of ₪81.63 million, both higher than the figures reported a year earlier. See our latest analysis for Sano Bruno's Enterprises. The latest quarterly update comes after a mixed period for the stock, with the share price up 5.73% over the past week but down 8.07% over the past month, while the 1-year and 3-year total shareholder returns of...